Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) and Sartorius (OTCMKTS:SARTF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.
Profitability
This table compares Fresenius Medical Care AG & Co. KGaA and Sartorius’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Fresenius Medical Care AG & Co. KGaA | 4.88% | 8.90% | 4.05% |
| Sartorius | 3.82% | 8.19% | 3.15% |
Earnings & Valuation
This table compares Fresenius Medical Care AG & Co. KGaA and Sartorius”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Fresenius Medical Care AG & Co. KGaA | $22.20 billion | 0.58 | $1.11 billion | $1.90 | 12.49 |
| Sartorius | $3.66 billion | 2.04 | $90.90 million | $2.15 | 101.23 |
Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Sartorius. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Sartorius, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Sartorius has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Fresenius Medical Care AG & Co. KGaA and Sartorius, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Fresenius Medical Care AG & Co. KGaA | 5 | 4 | 0 | 0 | 1.44 |
| Sartorius | 0 | 0 | 0 | 1 | 4.00 |
Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $28.00, indicating a potential upside of 17.97%. Given Fresenius Medical Care AG & Co. KGaA’s higher possible upside, equities analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Sartorius.
Institutional and Insider Ownership
8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Fresenius Medical Care AG & Co. KGaA beats Sartorius on 7 of the 13 factors compared between the two stocks.
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
About Sartorius
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
